Efficacy of Surgical Excision in Combination with Mitomycin C and Postoperative Topical 0.002% Mitomycin C Administration for Treatment of Conjunctival Intraepithelial Neoplasia

Purpose: To evaluate the efficacy of surgical excision in combination with mitomycin C (mit-C) and postoperative topical mit-C 0.002% administration for the treatment of conjunctival intraepithelial neoplasia (CIN). Material and Method: Twelve eyes of twelve patients who were histopathologically d...

Full description

Bibliographic Details
Main Authors: Özlen Rodop Özgür, Nadire Erdoğan, Yeşim Oral, Ömer Kamil Doğan
Format: Article
Language:English
Published: Galenos Yayinevi 2011-08-01
Series:Türk Oftalmoloji Dergisi
Subjects:
_version_ 1797922943395692544
author Özlen Rodop Özgür
Nadire Erdoğan
Yeşim Oral
Ömer Kamil Doğan
author_facet Özlen Rodop Özgür
Nadire Erdoğan
Yeşim Oral
Ömer Kamil Doğan
author_sort Özlen Rodop Özgür
collection DOAJ
description Purpose: To evaluate the efficacy of surgical excision in combination with mitomycin C (mit-C) and postoperative topical mit-C 0.002% administration for the treatment of conjunctival intraepithelial neoplasia (CIN). Material and Method: Twelve eyes of twelve patients who were histopathologically diagnosed as CIN between March 2004 and July 2008 were evaluated retrospectively for their treatment modalities and results. All lesions were excised with wide margins in combination with mit-C 0.02% application for 2 minutes. Five of 12 eyes were treated with topical mit-C 0.002% eye drops four times a day for 14 days after histopathological confirmation. Large conjunctival defects in 5 eyes were reconstructed with amniotic membrane (3 eyes) and autologous conjunctiva (2 eyes). Results: Seven patients were women and 5 were men, with a mean age of 68.37 (range: 30-94) years. The right eye was involved in 6 patients and the left one - in 6 patients. The conjunctival lesion was located on the nasal conjunctiva in 5 eyes and on the temporal one - in 7 eyes. Histopathological diagnosis was CIN in all cases. After a mean follow-up period of 41.75 months (between 10 and 62 months), one recurrence (8.3%) was noted. This case with recurrent lesion has been previously treated with surgical excision in combination with mit-C 0.02% application and the large conjunctival defect has been reconstructed with amniotic membrane. Discussion: Surgical excision in combination with mit-C and use of additional postoperative topical mit-C 0.002% in selected cases for conjunctival intraepithelial treatment provides a safe and effective cure. (Turk J Ophthalmol 2011; 41: 138-42)
first_indexed 2024-04-10T14:40:16Z
format Article
id doaj.art-516a5642649e4331a828f86b9d97c64c
institution Directory Open Access Journal
issn 1300-0659
2147-2661
language English
last_indexed 2024-04-10T14:40:16Z
publishDate 2011-08-01
publisher Galenos Yayinevi
record_format Article
series Türk Oftalmoloji Dergisi
spelling doaj.art-516a5642649e4331a828f86b9d97c64c2023-02-15T16:08:15ZengGalenos YayineviTürk Oftalmoloji Dergisi1300-06592147-26612011-08-0141313814210.4274/tjo.41.181890Efficacy of Surgical Excision in Combination with Mitomycin C and Postoperative Topical 0.002% Mitomycin C Administration for Treatment of Conjunctival Intraepithelial NeoplasiaÖzlen Rodop Özgür0Nadire Erdoğan1Yeşim Oral2Ömer Kamil Doğan3Dr. Lütfi K›rdar Kartal E¤itim ve Araflt›rma Hastanesi, 1. Göz Klini¤i, ‹stanbul, TürkiyeKocaeli Devlet Hastanesi, Göz Klini¤i, Kocaeli, TürkiyeDr. Lütfi K›rdar Kartal E¤itim ve Araflt›rma Hastanesi, 1. Göz Klini¤i, ‹stanbul, TürkiyePaflabahçe Devlet Hastanesi, Göz Klini¤i, ‹stanbul, TürkiyePurpose: To evaluate the efficacy of surgical excision in combination with mitomycin C (mit-C) and postoperative topical mit-C 0.002% administration for the treatment of conjunctival intraepithelial neoplasia (CIN). Material and Method: Twelve eyes of twelve patients who were histopathologically diagnosed as CIN between March 2004 and July 2008 were evaluated retrospectively for their treatment modalities and results. All lesions were excised with wide margins in combination with mit-C 0.02% application for 2 minutes. Five of 12 eyes were treated with topical mit-C 0.002% eye drops four times a day for 14 days after histopathological confirmation. Large conjunctival defects in 5 eyes were reconstructed with amniotic membrane (3 eyes) and autologous conjunctiva (2 eyes). Results: Seven patients were women and 5 were men, with a mean age of 68.37 (range: 30-94) years. The right eye was involved in 6 patients and the left one - in 6 patients. The conjunctival lesion was located on the nasal conjunctiva in 5 eyes and on the temporal one - in 7 eyes. Histopathological diagnosis was CIN in all cases. After a mean follow-up period of 41.75 months (between 10 and 62 months), one recurrence (8.3%) was noted. This case with recurrent lesion has been previously treated with surgical excision in combination with mit-C 0.02% application and the large conjunctival defect has been reconstructed with amniotic membrane. Discussion: Surgical excision in combination with mit-C and use of additional postoperative topical mit-C 0.002% in selected cases for conjunctival intraepithelial treatment provides a safe and effective cure. (Turk J Ophthalmol 2011; 41: 138-42)Conjuntivaintraepithelial neoplasiamitomycin Csurgery
spellingShingle Özlen Rodop Özgür
Nadire Erdoğan
Yeşim Oral
Ömer Kamil Doğan
Efficacy of Surgical Excision in Combination with Mitomycin C and Postoperative Topical 0.002% Mitomycin C Administration for Treatment of Conjunctival Intraepithelial Neoplasia
Türk Oftalmoloji Dergisi
Conjuntiva
intraepithelial neoplasia
mitomycin C
surgery
title Efficacy of Surgical Excision in Combination with Mitomycin C and Postoperative Topical 0.002% Mitomycin C Administration for Treatment of Conjunctival Intraepithelial Neoplasia
title_full Efficacy of Surgical Excision in Combination with Mitomycin C and Postoperative Topical 0.002% Mitomycin C Administration for Treatment of Conjunctival Intraepithelial Neoplasia
title_fullStr Efficacy of Surgical Excision in Combination with Mitomycin C and Postoperative Topical 0.002% Mitomycin C Administration for Treatment of Conjunctival Intraepithelial Neoplasia
title_full_unstemmed Efficacy of Surgical Excision in Combination with Mitomycin C and Postoperative Topical 0.002% Mitomycin C Administration for Treatment of Conjunctival Intraepithelial Neoplasia
title_short Efficacy of Surgical Excision in Combination with Mitomycin C and Postoperative Topical 0.002% Mitomycin C Administration for Treatment of Conjunctival Intraepithelial Neoplasia
title_sort efficacy of surgical excision in combination with mitomycin c and postoperative topical 0 002 mitomycin c administration for treatment of conjunctival intraepithelial neoplasia
topic Conjuntiva
intraepithelial neoplasia
mitomycin C
surgery
work_keys_str_mv AT ozlenrodopozgur efficacyofsurgicalexcisionincombinationwithmitomycincandpostoperativetopical0002mitomycincadministrationfortreatmentofconjunctivalintraepithelialneoplasia
AT nadireerdogan efficacyofsurgicalexcisionincombinationwithmitomycincandpostoperativetopical0002mitomycincadministrationfortreatmentofconjunctivalintraepithelialneoplasia
AT yesimoral efficacyofsurgicalexcisionincombinationwithmitomycincandpostoperativetopical0002mitomycincadministrationfortreatmentofconjunctivalintraepithelialneoplasia
AT omerkamildogan efficacyofsurgicalexcisionincombinationwithmitomycincandpostoperativetopical0002mitomycincadministrationfortreatmentofconjunctivalintraepithelialneoplasia